CEACAM5 and neoplasm: It is crucial to evaluate multiple factors when choosing the best treatment for each patient: tumor prognostic factors (disease-free interval, CEA level, RAS or BRAF mutations, number and size of metastases), patient factors (frailty and comorbidities), anatomic characteristics of M1 (size and location), center experience, and patient preferences (Figure 3).